Latest news
Sarepta Stock Dips After Hours: DMD Drug Blow And CEO Exit Eclipse Q4 Revenue Beat - StocktwitsStocktwits · Fri, 07 Aug 2026 17:26:02 GMTCAPR Stock Eyes Worst Week Ever After FDA Panel Blow To Deramiocel — Retail Bulls Still See A Path To Approval - TradingViewTradingView · Thu, 30 Jul 2026 03:07:00 GMTFDA advisory committee finds Capricor Therapeutics hasn’t proved its muscular dystrophy drug works against cardiomyopathy - POLITICO ProPOLITICO Pro · Wed, 29 Jul 2026 21:57:18 GMT